About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5905569
Allelic
Composition
Esrrbtm1.1Nat/Esrrbtm1.1Nat
Tg(Myh6-cre)2182Mds/0
Genetic
Background
involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Esrrbtm1.1Nat mutation (1 available); any Esrrb mutation (211 available)
Tg(Myh6-cre)2182Mds mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• poor survival rates after 9-10 months of age

cardiovascular system
• increase in heart weight to body weight and heart weight to tibial length ratios
• increase in fibrosis in the left ventricle
• mice develop adult-onset dilated cardiomyopathy associated with a decrease in anterior wall thickness, increased left ventricular end systolic diameter and left ventricular end diastolic diameter and a 60% decrease in fractional shortening
• decrease in cardiac function at 9 months of age but not at 4 and 6 months, with a 60% decrease in fractional shortening
• ventricular cardiomyocytes exhibit impaired contractility and show a decrease in both contractile distance (sarcomere shortening) and speed of contraction at 6 and 9 months of age
• ventricular cardiomyocytes exhibit impaired calcium handling and deregulation of the excitation-contraction coupling apparatus
• ventricular cardiomyocytes exhibit decreased calcium release and a trend towards decreased calcium uptake as early as 4 months of age
• by 6 months of age, calcium release and uptake by ventricular cardiomyocytes are increased and this persists at 9 months
• increase in calcium transients at 6 and 9 months of age
• expression analysis indicates a heart failure gene signature in hearts

muscle
• mice develop adult-onset dilated cardiomyopathy associated with a decrease in anterior wall thickness, increased left ventricular end systolic diameter and left ventricular end diastolic diameter and a 60% decrease in fractional shortening
• decrease in cardiac function at 9 months of age but not at 4 and 6 months, with a 60% decrease in fractional shortening
• ventricular cardiomyocytes exhibit impaired contractility and show a decrease in both contractile distance (sarcomere shortening) and speed of contraction at 6 and 9 months of age
• ventricular cardiomyocytes exhibit an increase in sarcomere length only after 9 months of age

growth/size/body
• increase in heart weight to body weight and heart weight to tibial length ratios

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
dilated cardiomyopathy DOID:12930 OMIM:PS115200
J:241078


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory